fluoxetine has been researched along with n-methylaspartate in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (18.75) | 18.2507 |
| 2000's | 4 (25.00) | 29.6817 |
| 2010's | 9 (56.25) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, C; Caldwell, L; Kinnier, WJ; Lancaster, J; McMillan, B; Price, CH; Sweetnam, PM | 1 |
| Black, CK; Fadayel, GM; Kehne, JH; McCloskey, TC; Schmidt, CJ; Taylor, VL | 1 |
| Chappell, RL; Schuette, E | 1 |
| Cao, JB; Guan, TT; Li, YF; Liu, YQ; Luo, ZP; Wang, HL; Zhang, YZ | 1 |
| Fonteles, MM; Freitas, RM; Sousa, FC; Viana, GS | 1 |
| Barbiero, VS; Longordo, F; Luccini, E; Pittaluga, A; Popoli, M; Racagni, G; Raiteri, L; Raiteri, M | 1 |
| Kiss, JP; Mayer, A; Szasz, BK | 1 |
| Crespi, F | 1 |
| Boeckers, TM; Fegert, JM; Föhr, KJ; Fulda, S; Koelch, M; Liebau, S; Ludolph, AG; Schaz, U | 1 |
| Cryan, JF; Dinan, TG; O' Connor, RM; Pusceddu, MM | 1 |
| Cavolo, SL; Colgan, LA; Commons, KG; Levitan, ES | 1 |
| Adeyemi, OI; Akanmu, MA; Owolabi, RA | 1 |
| Bum, EN; Moto, FC; Ngoupaye, GT; Taiwe, GS; Talla, E | 1 |
| Calabrese, B; Halpain, S | 1 |
| Corrêa da Silva, JA; da Silva, LM; de Souza, MM; Holzmann, I; Steimbach, VM | 1 |
| Barygin, OI; Belinskaya, DA; Nagaeva, EI; Shestakova, NN; Tikhonov, DB; Vanchakova, NP | 1 |
1 review(s) available for fluoxetine and n-methylaspartate
| Article | Year |
|---|---|
The role of receptor binding in drug discovery.
Topics: Animals; Drug Design; Humans; Receptors, Drug | 1993 |
15 other study(ies) available for fluoxetine and n-methylaspartate
| Article | Year |
|---|---|
Effects of the serotonin releasers 3,4-methylenedioxymethamphetamine (MDMA), 4-chloroamphetamine (PCA) and fenfluramine on acoustic and tactile startle reflexes in rats.
Topics: 5,7-Dihydroxytryptamine; Animals; Dose-Response Relationship, Drug; Fenfluramine; Fluoxetine; Indenes; Male; N-Methylaspartate; p-Chloroamphetamine; Rats; Rats, Inbred Strains; Reflex, Acoustic; Reflex, Startle; Serotonin; Touch | 1992 |
Excitatory amino acids and serotonin uptake blockers reveal two physiologically distinct serotonin systems in the retina of the skate, Raja erinacea.
Topics: Animals; Aspartic Acid; Excitatory Amino Acid Antagonists; Fluoxetine; Monoamine Oxidase Inhibitors; N-Methylaspartate; Organ Culture Techniques; Pargyline; Potassium; Retina; Selective Serotonin Reuptake Inhibitors; Serotonin; Skates, Fish; Zimeldine | 1998 |
Inhibition of N-methyl-D-aspartate receptor function appears to be one of the common actions for antidepressants.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Calcium; Calcium Signaling; Cell Survival; Desipramine; Excitatory Amino Acid Antagonists; Fluoxetine; Hippocampus; L-Lactate Dehydrogenase; Moclobemide; Monoamine Oxidase Inhibitors; N-Methylaspartate; Neurons; Nitric Oxide Synthase Type I; PC12 Cells; Rats; Receptors, N-Methyl-D-Aspartate; Signal Transduction; Tetrazolium Salts; Thiazoles | 2006 |
Effect of gabaergic, glutamatergic, antipsychotic and antidepressant drugs on pilocarpine-induced seizures and status epilepticus.
Topics: Amines; Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Fluoxetine; Gabapentin; gamma-Aminobutyric Acid; Humans; Ketamine; Male; Muscarinic Agonists; N-Methylaspartate; Pilocarpine; Pimozide; Rats; Seizures; Status Epilepticus | 2006 |
Antidepressant treatments and function of glutamate ionotropic receptors mediating amine release in hippocampus.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amines; Animals; Antidepressive Agents; Corpus Striatum; Drug Interactions; Excitatory Amino Acid Agents; Fluoxetine; Gene Expression; Hippocampus; Male; Morpholines; N-Methylaspartate; Potassium; Rats; Rats, Sprague-Dawley; Reboxetine; Receptors, Glutamate; Synaptosomes; Time Factors; Tritium | 2007 |
Inhibitory effect of antidepressants on the NMDA-evoked [(3)H]noradrenaline release from rat hippocampal slices.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Desipramine; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Fluoxetine; Hippocampus; Male; N-Methylaspartate; Neural Inhibition; Neurons; Norepinephrine; Organ Culture Techniques; Rats; Rats, Wistar; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Sodium Channel Blockers; Tritium | 2009 |
The selective serotonin reuptake inhibitor fluoxetine reduces striatal in vivo levels of voltammetric nitric oxide (NO): a feature of its antidepressant activity?
Topics: Anesthesia; Animals; Antidepressive Agents, Second-Generation; Corpus Striatum; Electrochemical Techniques; Electrodes, Implanted; Enzyme Inhibitors; Fluoxetine; Male; N-Methylaspartate; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Selective Serotonin Reuptake Inhibitors | 2010 |
Dose-dependent modulation of apoptotic processes by fluoxetine in maturing neuronal cells: an in vitro study.
Topics: Animals; Apoptosis; Brain; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Electrophysiology; Fluoxetine; HEK293 Cells; Humans; Immunohistochemistry; In Vitro Techniques; N-Methylaspartate; Neurons; Rats; Receptors, GABA; Selective Serotonin Reuptake Inhibitors | 2011 |
Impact of early-life stress, on group III mGlu receptor levels in the rat hippocampus: effects of ketamine, electroconvulsive shock therapy and fluoxetine treatment.
Topics: Animals; Antidepressive Agents; Electroshock; Excitatory Amino Acid Antagonists; Fluoxetine; Hippocampus; Ketamine; Male; Maternal Deprivation; N-Methylaspartate; Rats; Rats, Sprague-Dawley; Receptors, Metabotropic Glutamate; Stress, Psychological | 2013 |
Action potential-independent and pharmacologically unique vesicular serotonin release from dendrites.
Topics: Action Potentials; Animals; Calcium Channels, L-Type; Dendrites; Excitatory Amino Acid Agonists; Fluoxetine; Male; N-Methylaspartate; Neurons; Rats; Rats, Sprague-Dawley; Secretory Vesicles; Selective Serotonin Reuptake Inhibitors; Serotonin; Vesicular Monoamine Transport Proteins | 2012 |
Effects of ketamine and N-methyl-D-aspartate on fluoxetine-induced antidepressant-related behavior using the forced swimming test.
Topics: Animals; Antidepressive Agents, Second-Generation; Behavior, Animal; Depression; Fluoxetine; Ketamine; Mice; N-Methylaspartate; Receptors, N-Methyl-D-Aspartate; Swimming; Synaptic Transmission | 2014 |
Antidepressant properties of aqueous macerate from Gladiolus dalenii corms.
Topics: 2-Amino-5-phosphonovalerate; Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Depression; Fluoxetine; Hindlimb Suspension; Imipramine; Iridaceae; Male; Medicine, African Traditional; Mice; Motor Activity; N-Methylaspartate; Phytotherapy; Plant Extracts; Receptors, N-Methyl-D-Aspartate; Selective Serotonin Reuptake Inhibitors; Stress, Psychological; Swimming | 2014 |
Lithium prevents aberrant NMDA-induced F-actin reorganization in neurons.
Topics: Actins; Animals; Antidepressive Agents; Antipsychotic Agents; Cells, Cultured; Cytoskeleton; Dendrites; Dose-Response Relationship, Drug; Fluoxetine; Glycogen Synthase Kinase 3; Hippocampus; Imipramine; Lithium Chloride; N-Methylaspartate; Neurons; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Time Factors | 2014 |
Antidepressant-like effect of quercetin in bulbectomized mice and involvement of the antioxidant defenses, and the glutamatergic and oxidonitrergic pathways.
Topics: Animals; Antidepressive Agents; Antioxidants; Arginine; Behavior, Animal; Disease Models, Animal; Drug Synergism; Fluoxetine; Hippocampus; Indazoles; Male; Methylene Blue; Mice; N-Methylaspartate; Olfactory Bulb; Oxidative Stress; Quercetin; Signal Transduction; Sildenafil Citrate | 2015 |
Inhibition of the NMDA and AMPA receptor channels by antidepressants and antipsychotics.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Atomoxetine Hydrochloride; Brain; Chlorpromazine; Citalopram; Desipramine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fluoxetine; Magnesium; Male; Membrane Potentials; N-Methylaspartate; Neurons; Neurotransmitter Agents; Rats, Wistar; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate | 2017 |